On Friday, February 24, 2017, KEI hosted a meeting exploring compulsory licensing in the United States.
Title: History, Experiences, and Prospects of Compulsory Licensing on Medical Patents in the United States
Date: Friday February 24, 2017
Location: Kaiser Permanente Center for Total Health
700 Second St. NE (near Union Station)
Washington, DC 20002
Continue Reading →
National Institutes of Health Declines to Exercise Authority to Lower Xtandi Price
The National Institutes of Health will not use its rights under the Bayh-Dole Act to end the monopoly on the expensive prostate cancer drug Xtandi and allow low-priced generic versions to compete on the market.
Continue Reading →
On March 28, 2016, six Senators and six members of the House of Representatives sent a letter to HHS Secretary Burwell and Director Collins at NIH, calling for an “open and transparent public hearing” to discuss the issues presented in… Continue Reading →
For more information on the 2021-2022 Xtandi request please visit: https://www.keionline.org/xtandi2021 (More on government funded inventions here.) On January 14, 2016, Knowledge Ecology International (KEI) and the Union for Affordable Cancer Treatment (UACT) submitted a request to the National Institutes… Continue Reading →
This was the release from Representative Doggett’s office:
FOR IMMEDIATE RELEASE
January 11, 2016
Contact:
Leslie Tisdale, (202) 225-4865
Over 50 Members of Congress to Obama Administration:
Help End Drug Price Gouging Now
Continue Reading →
The 1980 Bayh-Dole Act is named after two former US Senators, Birch Bayh and Bob Dole. In 2002 both claimed the Bayh-Dole Act march-in provisions were not intended to address cases where prices for inventions are unreasonable, and Senator Bayh repeated this view during a 2004 march-in case involving Abbott patents on ritonavir.
Among the provisions of the Act that suggest otherwise are the following:
Continue Reading →
For more information, KEI general page on the Bayh Dole Act, or one of the mini Bayh-Dole timelines, such as the ones on transparency, march-in rights or royalty free uses. TIMELINE 1980 1980. October 21. Public Law 96-480. Stevenson-Wydler Technology… Continue Reading →
Ralph Nader P.O. Box 19312 Washington, DC 20036 July 23, 2001 Dr. Gro Harlem Brundtland Director-General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Dr. Brundtland: It has been encouraging in recent years to see the WHO… Continue Reading →
July 6, 2001 Mr. Ralph Nader P.O. Box 19312 Washington, D.C. 20036 Dear Mr. Nader: I am writing in response to the letter from you and your colleagues requesting that the Department of Health and Human Services (HHS) grant the… Continue Reading →
Ralph Nader P.O. Box 19312 Washington, DC 20036 James Love Consumer Project on Technology P.O. Box 19367 Washington, DC 20036 Robert Weissman Essential Action P.O. Box 19405 Washington, DC 20036 March 28, 2001 Secretary Tommy Thompson Department of Health and… Continue Reading →
